Aim & Scope
Women’s’ Health Bulletin (WHB) is a quarterly peer-reviewed journal, the aim of which is to provide a scientific medium of communication for researchers throughout the globe.
The journal considers articles on all aspects of the health and health care of adolescent girls and women, with a particular focus on the prevention, diagnosis, and management of disorders and diseases related to them, as well as related genetics, pathophysiology, epidemiology, clinical reports, and controlled trials.
It is journal policy to publish work deemed by peer reviewers to be a coherent and sound addition to scientific knowledge and to put less emphasis on interest levels, provided that the research constitutes a useful contribution to the field. Manuscripts are publishable in the form of review article, original article, brief report, case report, commentary, editorial, and letter to editor.
All editor-in-chiefs and associate editors as well as the reviewers of Women’s Health Bulletin are completely independent from the publisher and free to make decisions without any interference from the owners of their journals or their publisher.
Processing Fee Policy
This journal has no article submission or peer review processing charges and also does not charge authors for accepting articles.
Since Women's Health Bulletin does not have article processing charge and publication fee, the authors are asked to transfer the copyright of accepted manuscripts and also publishing right to the Journal.
Fast Track System: To facilitate a speedy turn-around when a rapid decision is required, Women's Health Bulletin offers a review model in which selected peer reviewers may be paid to deliver high-quality and speedy peer-review reports. This is optional - if you do not wish to pay for a fast-track peer review process, just submit your paper normally as described before in the instruction for authors. If you opt for fast track review, you are guaranteed: a rapid editorial decision and peer-review comments within 10 working days after submission and payment of the fee.
Review will no guarantee a manuscript to be accepted but it makes the judging process faster than the routine review process.
Fast Track Fee: 1,500,000 Rials
For more information regarding fast track fee, please refer to this link.
The Journal accepts manuscripts only through the online submission system, easy to use and easy to track, thus the submission will be done rather faster by electronically submission.
Scientific and Initial Screening:
Once you submit an article, it will be forwarded to one of the editors and afterwards to at least two peer-reviewers. At once after submission, the author will be notified of the both submission process via the email and the follow-up ID code. It is recommended to save the sent ID code for all the next correspondence regarding each article, separately.
• Women's Health Bulletin uses double-blind review, which means that both the reviewer and author identities are concealed from the reviewers, and vice versa, throughout the review process.
• All submitted manuscripts are subjected to the external peer review and editorial approval.
• Articles will be sent to at least 3 independent reviewers in the related field.
• Normally, the reviewers are blinded to the authors' identities and their affiliations while the associate editors have full access to them.
• Authors are usually notified within 2-3 months about the acceptability of their manuscript.
• Reviewers are selected based on their expertise within the topic area of the submission, and their purpose is to assist the authors and the journal by providing a critical review of the manuscript. To apply as a reviewer in our journal, please send your request with your resume to email@example.com. The editorial board of the journal will review your resume and will be in contact with you.
• After receiving the reviewers’ comments, authors are requested to send the revised article and a copy of their reply to the reviewers including the comment and explaining the replies to the questions and the changes made to the revised version. The communication regarding a specific manuscript will be done only between the journal and the designated corresponding author.
The Journal is a member of the Committee on Publication Ethics (COPE). COPE’s flowcharts and guidelines are approached in confronting any ethical misbehavior. The Journal also follows the guidelines mentioned in the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals issued by the International Committee of Medical Journal Editors (ICMJE).
Based on the ICMJE, authorship criteria are as below:
1. Substantial contributions to the conception or design of the work, or the acquisition, analysis or interpretation of data.
2. Drafting the work or revising it critically for important intellectual content.
3. Final approval of the version published.
4. Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
In addition to being accountable for the parts of the work he or she has done, an author should be able to identify which co-authors are responsible for specific other parts of the work. In addition, authors should have confidence in the integrity of the contributions of their coauthors. All those designated as authors should meet all four criteria for authorship, and all who meet the four criteria should be identified as authors. Those who do not meet all four criteria should be listed in an Acknowledgements section. Participation solely in the acquisition of funding, the gathering of data, technical help, writing assistance, and general supervision of the research group does not warrant authorship. Financial and material support should also be acknowledged. Please guarantee that anyone stated in the Acknowledgements section has granted its clearance for permission to be listed.
An authorship statement is required for every manuscript submitted and should state who has contributed what to the planning, conducting, and reporting of the work described in the article.
Conflict of Interest:
A competing interest exists when professional judgment concerning a primary interest (such as patients’ welfare or the validity of research) may be influenced by a secondary interest (such as financial gain - employment, Consultancy, stock ownership or options, honoraria, patents, and paid expert- testimony or personal relationship). There is nothing unethical about a competing interest but it should be acknowledged and clearly stated. All authors must declare all competing interests in their covering letter and in the “Competing Interests” section at the end of the manuscript file (before the references). Authors with no competing interests to declare should obviously state that.
Authors are preferably asked to fill the uniform disclosure form available through:
If a manuscript contains any previous published image or text, it is the responsibility of the author to obtain authorization from copyright holders. The author is required to obtain and submit the written original permission letters for all copyrighted material used in his/her manuscript.
Since Women's Health Bulletin does not have article processing charges and publication fees, the authors are asked to transfer the copyright of accepted manuscripts and also publishing right to the Journal.
Open Access Policy:
This journal provides immediate open access to its content on the principle that making research freely available to the public and supports a greater global exchange of knowledge.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Women's Health Bulletin uses the COPE flowchart for retraction of a published article to determine whether a published article should be retracted.
Complaints and appeals
Women's Health Bulletin responds promptly to complaints and ensures there is a way for dissatisfied complainants to take complaints further by sending an email to editor-in-chief of the journal. We follow the COPE's guidelines and flowcharts for handling complaints against the journal, its staff, editorial board, or publisher.
Submitting a manuscript which is published previously in Persian or any other language, is supposed as a research misconduct, and it is not acceptable by this journal; so authors should accept the outcomes.
Language and Style:
Contributions should be in either American or British English. The text must be clear and concise, conforming to accepted standards of English style and usage. Non-native English speakers are advised to seek professional help with the language.
Abbreviations should be standard and used just in necessary cases, after complete explanations in the first usage. The editorial office reserves the right to edit the submitted manuscripts in order to comply with the Journal’s style. In any case, the authors are responsible for the published material.
Requirements for Different Types of Articles
Research Articles also are called “Original Articles”, which are considered as the common types of articles. The content of the paper must justify its length.
Abstract: A structured abstract is required including these headings:
For the original research, traditional sections are required including:
- Acknowledgments (if applicable)
In the full text of an original article, the maximum number of:
- Word Count: 3000-3500 (excluding the references, abstract, figures, and tables)
- References are: 15-40
- Illustrations or tables are 5
Clinical trials: The format is similar to original articles. However, the CONSORT flow diagram should be added as a figure. RCTs should be registered at any RCT Registry approved by the WHO and their registration number should be mentioned in the title page. RCTs done in Iran must be registered at www.irct.ir.
- Short manuscripts definitively documenting either experimental results or informative clinical observations will be considered for publication in this category.
- Brief Reports are not intended to allow publication of incomplete or preliminary findings.
- The review process is equally rigorous as for Regular Articles.
- Another name of this type is "Short communication"
Abstracts must not exceed 200 words and should be a single paragraph with no subheadings.
Brief Reports may not exceed 2000 words of text -counting only:
- Acknowledgments (if applicable)
- In a brief report, the maximum number of:
- Tables or figures are 2
- References are 10-15
A case report is a case study, case report, or other description of a case that should contain a structured abstract. In the other meaning, clinical presentations may be followed by evaluative studies that eventually lead to a diagnosis. Case reports should optimally be accompanied by relevant figures to document findings. Informed consents should be obtained from the patients to report their cases. The Journal keeps the right to ask for original signed informed consents.
Abstract of Case reports should comprise the below sections:
- Case Presentation
Full text of a case report includes:
- Case Presentation
- Acknowledgment (if applicable)
- In a case report, the maximum number of:
- Tables or figures are 2
- References are 5-10
State-of-the-art reviews tend to address more current matters including a review of the literature. This type of article summarizes the current state of understanding on a topic. A review article surveys and summarizes previously published studies, rather than reporting new facts or analysis. The word count should not exceed 4500 words.
The structured abstract of a review article contains the below headings:
- Evidence Acquisition
The full text of a review article contains the below sections:
- Context: It includes 1 or 2 sentences describing the clinical question or issue and its importance in clinical practice or public health.
- Evidence Acquisition: This section describes the data sources, including the research strategies, time of the study, and other sources of the used materials, such as subsequent reference searches of retrieved articles. It explains the methods used for quality assessment and the inclusion of identified articles.
- Results: This section addresses the major findings of the review of the clinical issue or topic in an evidence-based, objective, and balanced style, emphasizing the available highest-quality evidence.
- Conclusions: It clearly states the conclusions to answer the posed questions, if applicable, based on the conclusions of the available evidence, and it emphasizes how clinicians should apply the current knowledge.
- In a review article, the maximum number of:
- References are 80
- Illustrations or table are 5
-Narrative reviews: Should contain at least 60 references. The word count should not exceed 4500 words. Narrative reviews should critically assess the current knowledge of the field. The structured abstract should contain these headings: Context, Evidence Acquisition, Results, Conclusions.
- Systematic Review or Meta-Analysis:
Authors should report systematic reviews and meta-analyses in accordance with the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) statement. Systematic Reviews maximum number of references is 40, the maximum number of illustrations/Tables is 6. For Systematic Reviews, both abstract and text of the manuscript should be subdivided into the following sequential sections:
1) Context: Provide a sentence or two explaining the importance of the review question. Also, state the precise primary objective of the review. Indicate whether the review emphasizes factors such as cause, diagnosis, prognosis, therapy, or prevention and include information about the specific population, intervention, exposure, and tests or outcomes that are being reviewed.
2) Methods: Succinctly summarize data sources, including years searched. Include in the search the most current information possible, ideally conducting the search several months before the date of manuscript submission. Then, describe inclusion and exclusion criteria used to select studies for detailed review from among studies identified as relevant to the topic. Under details of selection include particular populations, interventions, outcomes, or methodological designs. Specify the method used to apply these criteria (for example, blinded review, consensus, multiple reviewers). State the proportion of initially identified studies that met selection criteria. Also, describe guidelines used for abstracting data and assessing data quality and validity (such as criteria for causal inference). State the method by which the guidelines were applied (eg, independent extraction by multiple observers).
3) Results: State the main results of the review, whether qualitative or quantitative, and outline the methods used to obtain these results. For meta-analyses, state the major outcomes that were pooled and include odds ratios or effect sizes and, if possible, sensitivity analyses. Accompany numerical results by confidence intervals, if applicable, and exact levels of statistical significance. For evaluations of screening and diagnostic tests, include sensitivity, specificity, likelihood ratios, receiver operating characteristic curves, and predictive values. For assessments of prognosis, summarize survival characteristics and related variables. State the major identified sources of variation between studies, including differences in treatment protocols, protocols, co-interventions, confounders, outcome measures, length of follow-up, and dropout rates.
4) Conclusions: Clearly state the conclusions and their applications (clinical or otherwise), limiting interpretation to the domain of the review.
Systematic reviews are welcome. They should be critical assessments of current evidence covering a broad range of topics of concern to those working in the specific field of journal. Systematic reviews abstracts to be structured as above. N.B. For advice on writing systematic reviews consult: The Cochrane Reviewers' Handbook
A meta-analysis of observational studies: A MOOSE checklist is required for the meta-analysis of observational studies.
Letter to Editor
Letters to Editor about a recent journal article are referring to a recent article in this journal must be received within three months of its publication. For example, a letter referring to an article published in the January issue must be submitted online no later than March 31st. Letters submitted after the allowed time will not be considered. Letters will undergo peer review and will be edited for clarity.
- Word count: 700-1000
- A maximum of three (3) authors and 5 references are allowed.
- Neither tables nor figures are allowed.
LETTER is often accompanied by a REPLY.
- A modification or correction of previously published material; this is sometimes called “errata”.
- Correction refers to changes the author wants to introduce post-acceptance, at any time thereafter, during the publication processes or post-publication.
- If the author determines that it is scientifically necessary, then it should be made. A Correction is then created and published in the next available issue.
- In addition, it is linked online to the published article, and if the article is referenced, the Correction information should be included.
Correction as a new article
All corrections must be submitted in the journal website and will be reviewed by the Editor-in-Chief. After accepting a correction, this new article will be published in the journal.
The maximum word count of a correction is 250 words.
Preparation of Manuscript
Organization of the paper and style of presentation
Manuscripts must be written in English. Authors whose native language is not English are recommended to seek the advice of a native English speaker, if possible, before submitting their manuscripts.
Manuscripts should be prepared with wide margins and double spacing throughout, including the abstract, footnotes and references. Every page of the manuscript, including the title page, references, tables, etc., should be numbered. However, in the text, no reference should be made to page numbers; if necessary, one may refer to sections. Try to avoid the excessive use of italics and boldface.
Cover Letter should contain the rationale of performing the research and selecting Women's Health Bulletin as well as a statement that you will not resubmit your article to another journal until the reviewing process will be completed. Also please indicate whether the authors have published or submitted any related papers from the same study. The file is available by referring to this link.
Manuscripts should be organized in the following order:
- Title page
- Body of text (divided by subheadings)
Important note: all tables must be in a separate MS Word file with the correct reference to the text. Also, all Figures and photos must be in JPEG format and as a single file. Figures are only accepted as JPEG files at 300 dpi (dots per inch) or greater.
SI units should be used, i.e., those based on meters, kilograms, seconds, etc.
Title page (sample title page can be found by referring to this link: http://womenshealthbulletin.sums.ac.ir/page_22.html.
The title page should provide the following information:
-Type of Article
Title (should be clear, descriptive, and not too long)
- Name(s) of the author(s); please indicate who is the corresponding author
- Full affiliation(s)
- Complete address of the corresponding author, including telephone and fax numbers and e-mail address
- Abstract; should be clear, descriptive, self-explanatory, and not longer than 250 words, it should also be suitable for publication in abstracting services
-Running title: a shorter version of the title (40 characters at most) is needed.
Introduction should provide a context or background and specify the purpose or research objective of the study or observation.
Materials and Methods
Must indicate clearly the steps taken to acquire the information. Be sure that it includes only information that was available at the time the plan or protocol for the study was written. It should be detailed (including controls, inclusion and exclusion criteria, etc) and may be separated into subsections. Repeating the details of standard techniques is best avoided.
The software used for statistical analysis and description of the actual method should be mentioned.
Human and Animal Rights, and Informed Consent
All studies using human or animal subjects should include an explicit statement in the Materials and Methods section identifying the review and approval committee for each study. Editors reserve the right to reject papers if there is doubt whether appropriate procedures have been used.
Results should be presented in a chronological sequence in the text, table, and illustration. Organize the results according to their importance. They should result from your own study.
Number as Table 1, Table 2 etc, and refer to all of them in the text.
Each table should also be provided on a separate page.
Each table should have a brief and self-explanatory title.
Any explanations essential to the understanding of the table should be given in footnotes at the bottom of the table.
Number figures as Fig. 1, Fig. 2, etc and refer to all of them in the text.
Each figure should be provided on a separate sheet. They should also be as single JPEG files at 300 dpi or greater resolution.
Each figure should have a self-explanatory caption. Photographs are only acceptable if they have good contrast and brightness.
Discussion should emphasize the new and important aspects of the study and the conclusions that follow them. Possible mechanisms or explanations for these findings should be explored. The limitations of the study and the implications of the findings for future research or clinical practice should be explored.
Supplementary Materials such as movie clips, questionnaires, etc may be published on the online version of the journal.
Any technical help, general, financial, and material support or contributions that need acknowledging but do not justify authorship, can be cited at the end of the text as Acknowledgments.
References should be complied numerically according to the order of citation in the text in Vancouver style. The numbers of references should preferably not exceed 40 for original articles, 15 for brief report, 10 for case reports, and 5 for letter to editor. References should optimally be prepared with EndNote software. Women's Health Bulletin has its own EndNote style. Authors are advised to prepare their references based on this style. This style is available at this link.
For the references credited to more than 6 authors please provide the name of the first six authors and represent the remaining authors by the phrase “et al.”
For various references please refer to “the NLM style guide for authors, editors, and publishers”.
Listed below are sample references. Moreover, Women's Health Bulletin has its own EndNote style. Authors are advised to prepare their references based on this style. This style is available at this link.
• Gaydess A, Duysen E, Li Y, Gilman V, Kabanov A, Lockridge O, et al. Visualization of exogenous delivery of nanoformulated butyrylcholinesterase to the central nervous system. Chem Biol Interact. 2010;187(1):295-8. doi: 10.1016/j.cbi.2010.01.005. PubMed PMID: 20060815; PubMed Central PMCID: PMC2998607.
• Guyton AC. Textbook of Medical Physiology. 8th ed. Philadelphia, PA: Saunders; 1996.
Chapter in Book:
• Young VR. The role of skeletal muscle in the regulation of protein metabolism. In Munro HN, editor. Mammalian protein metabolism. Vol 4. San Diego: Academic; 1970. p. 585-674.
Organization as the author
- Diabetes Prevention Program Research Group. Hypertension, insulin, and proinsulin in participants with impaired glucose tolerance. Hypertension. 2002;40(5):679-86.
No author is given
- 21st century heart solution may have a sting in the tail. BMJ. 2002;325(7357):184.
Article not in English
- Ellingsen AE, Wilhelmsen I. Sykdomsangst blant medisin- og jusstudenter. Tidsskr Nor Laegeforen. 2002;122(8):785-7. Norwegian.
Article with published erratum
- Malinowski JM, Bolesta S. Rosiglitazone in the treatment of type 2 diabetes mellitus: a critical review. Clin Ther. 2000; 22(10):1151-68; discussion 1149-50. Erratum in: Clin Ther. 2001; 23(2):309.
Word Count of Abstract:
- An abstract of 250-350 words should be provided to state the reason for the study, the main findings and the conclusions drawn from the observation.
An abstract is required in:
- A Structured abstract is required for the below article types:
- Research Articles
- Review Articles
- Case Reports
- Brief Reports
When abstracting a review article, a concise summary of the salient points should be addressed.
The abbreviations should preferably not be mentioned in the abstract.
Keywords are used for indexing purposes.
A list of 3-10 keywords must be provided for indexing purposes. All keywords should be provided according to the MeSH terms at: http://www.nlm.nih.gov/mesh/MBrowser.html. Note that the preferred expression is indicated by the label "MeSH Heading" and not "Entry Term". The desired terms may then be copied from the MeSH Browser. Another way of finding appropriate headings is to search PubMed to find articles on similar topics, and review the MeSH headings assigned to those articles. To read more about Keywords click here.
- In the "Keywords" section, enter your manuscripts' keywords.
- Keywords can be separated using Tab or Enter button on keyboard or by clicking the keyword.
- If the entered keyword had been defined in the journal before, the system will suggest this keyword to the author.
- In other states, the author can enter his/her own keywords.
- Also, for deleting each keyword, author can simply click the delete sign on every keyword.
Correction of Errata:
The Journal will publish an erratum when a factual error in a published item has been documented.
The names and email addresses entered in the Journal's website will be used exclusively for the stated purposes and will not be made available for any other purpose or to any other party.
For further information, please contact the Editorial Office:
Postal address: Health Policy Research Center, Building No.2, 8th Floor, School of Medicine, Zand Avenue, Shiraz, IR Iran
- Postal Code: 71348-45794
- Tel/Fax: +98-71-32309615
- Email: firstname.lastname@example.org
- LinkedIn: Women's Health Bulletin